Skip to main content
. 2022 Jul 28;13(5):2352–2360. doi: 10.1002/jcsm.13055

Table 2.

Number and rates of transition in frailty status and mortality according to the presence or absence of sarcopenia

Fried phenotype Follow‐up group
Basal frailty state Basal sarcopenia state Robust Prefrail Frail P‐value Death P‐value Total
From robust No sarcopenic to (%) 639 (80.17) 121 (15.18) 9 (01.12) <0.001 28 (03.51) 0.13 797
Sarcopenic to (%) 85 (61.15) 45 (32.37) 8 (05.76) 1 (00.72) 139
From prefrail No sarcopenic to (%) 123 (52.56) 85 (36.32) 10 (04.27) <0.001 16 (06.84) 0.13 234
Sarcopenic to (%) 48 (33.80) 59 (41.55) 18 (12.68) 17 (11.97) 142
From frail No sarcopenic to (%) 2 (11.11) 9 (50.00) 2 (11.11) 0.32 5 (27.78) 0.89 18
Sarcopenic to (%) 3 (15.79) 7 (36.84) 4 (21.05) 5 (26.32) 19
FTS5 Follow‐up group
Basal frailty state Basal sarcopenia state No frail Frail P‐value Death P‐value Total
From no frail No sarcopenic 939 (91.25) 46 (04.47) <0.001 44 (04.28) 0.53 1,029
Sarcopenic 137 (70.98) 50 (25.91) 6 (03.11) 193
From frail No sarcopenic 8 (27.59) 14 (48.28) 1.00 7 (24.14) 0.63 29
Sarcopenic 32 (30.19) 56 (52.83) 18 (16.98) 106

Data are shown as number and percentage. In bold: p‐value <0.05. Percentage adds up to 100 horizontally. FTS5: Frailty Trait Scale 5.